David Canes to Neoplasm Grading
This is a "connection" page, showing publications David Canes has written about Neoplasm Grading.
Connection Strength
0.149
-
Pockros B, Stensland KD, Parries M, Frankenberger E, Canes D, Moinzadeh A. Preoperative MRI PI-RADS scores are associated with prostate cancer upstaging on surgical pathology. Prostate. 2022 02; 82(3):352-358.
Score: 0.046
-
Moynihan MJ, Sullivan TB, Burks E, Schober J, Calabrese M, Fredrick A, Kalantzakos T, Warrick J, Canes D, Raman JD, Rieger-Christ K. MicroRNA profile in stage I clear cell renal cell carcinoma predicts progression to metastatic disease. Urol Oncol. 2020 10; 38(10):799.e11-799.e22.
Score: 0.041
-
Browne BM, Stensland KD, Patel CK, Sullivan T, Burks EJ, Canes D, Raman JD, Warrick J, Reiger-Christ KM. MicroRNA Expression Profiles in Upper Tract Urothelial Carcinoma Differentiate Tumor Grade, Stage, and Survival: Implications for Clinical Decision-Making. Urology. 2019 01; 123:93-100.
Score: 0.037
-
Harty NJ, Kozinn SI, Canes D, Sorcini A, Moinzadeh A. Comparison of positive surgical margin rates in high risk prostate cancer: open versus minimally invasive radical prostatectomy. Int Braz J Urol. 2013 Sep-Oct; 39(5):639-46; discussion 647-8.
Score: 0.026